000 -LEADER |
fixed length control field |
00779 a2200217 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20250626105421.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
250618b ||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780521563086 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
LC |
Transcribing agency |
UNZA |
Description conventions |
RDA |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM 281 |
Item number |
GAL 1995 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Galambos, Louis. |
Relator term |
author |
245 ## - TITLE STATEMENT |
Title |
Networks of innovation : |
Remainder of title |
vaccine development at Merck, Sharp and Dohme, and Mulford, 1895 - 1995 / |
Statement of responsibility, etc. |
Louis Galambos with Jane Eliot Sewell. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
Cambridge University Press, |
Date of publication, distribution, etc. |
1995. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xi, 273 pages : |
Other physical details |
illustrations. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes index. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Merck, Sharp & Dohme International |
General subdivision |
History. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Vaccines |
General subdivision |
History. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Vaccines industry |
General subdivision |
History. |
700 ## - ADDED ENTRY--PERSONAL NAME |
Personal name |
Sewell, Jane Eliot . |
Relator term |
author |
999 ## - |
-- |
214927 |
-- |
214927 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |